Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PROKIDNEY CORP. | Director | Director stock option (right to buy) | 62.6K | May 30, 2024 | Direct | ||
KalVista Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 10K | Oct 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KALV | KalVista Pharmaceuticals, Inc. | Oct 3, 2024 | 1 | $0 | 4 | Oct 4, 2024 | Director |
PROK | PROKIDNEY CORP. | May 30, 2024 | 1 | $0 | 4 | Jun 3, 2024 | Director |
KALV | KalVista Pharmaceuticals, Inc. | Sep 26, 2023 | 1 | $0 | 4 | Sep 28, 2023 | Director |
PROK | PROKIDNEY CORP. | Jun 29, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
KALV | KalVista Pharmaceuticals, Inc. | Oct 13, 2022 | 1 | $0 | 4 | Oct 17, 2022 | Director |
PROK | PROKIDNEY CORP. | Jul 11, 2022 | 2 | $0 | 4 | Jul 13, 2022 | Director |
PROK | PROKIDNEY CORP. | Jul 11, 2022 | 0 | $0 | 3 | Jul 13, 2022 | Director |
KALV | KalVista Pharmaceuticals, Inc. | Sep 30, 2021 | 1 | $0 | 4 | Oct 1, 2021 | Director |